Methylation status of the T-cadherin gene promotor in peripheral blood mononuclear cells is associated with HBV-related hepatocellular carcinoma progression
- 1 May 2020
- journal article
- research article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 216 (5) , 152914
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 20 references indexed in Scilit:
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Cadherin 13 in cancerGenes, Chromosomes and Cancer, 2010
- Genetic and epigenetic inactivation of T‐cadherin in human hepatocellular carcinoma cellsInternational Journal of Cancer, 2008
- Management of Hepatocellular Carcinoma *Hepatology, 2005
- Aberrant methylation of H‐cadherin (CDH13) promoter is associated with tumor progression in primary nonsmall cell lung carcinomaCancer, 2005
- Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectivesJournal of Cancer Research and Clinical Oncology, 2004
- Aberrant methylation of multiple genes in the upper aerodigestive tract epithelium of heavy smokersInternational Journal of Cancer, 2003
- Cadherin-13, a Mediator of Calcium-Dependent Cell-Cell Adhesion, Is Silenced by Methylation in Chronic Myeloid Leukemia and Correlates With Pretreatment Risk Profile and Cytogenetic Response to Interferon AlfaJournal of Clinical Oncology, 2003
- Is T-cadherin (CDH13, H-cadherin) expression related to lung metastasis of osteosarcoma?Histopathology, 2000
- H–cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancerNature Medicine, 1996